ARTICLE | Distillery Therapeutics
Neurology
December 19, 2017 8:54 PM UTC
Mouse studies suggest antisense oligonucleotides (ASOs) targeting the APOE variant APOE4 could help treat AD. In a mouse model of AD, intracerebroventricular injection of an ASO targeting APOE4 decrea...
BCIQ Company Profiles